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Conclusion: Presence of a chronic obstructive pulmonary disease is asso-
ciated with a doubling risk of all-cause death in CAD pts.
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Introduction: In degenerative mitral regurgitation (MR), brain natriuretic
peptide (BNP) is a surrogate biomarker of the consequences of MR on the left
ventricle (LV) and left atrium (LA). LV global longitudinal strain (GLS),
quantified by 2-D speckle-tracking imaging (2DSt) improved the detection of
subclinical LV dysfunction. We aimed evaluating the impact of BNP on out-
come and its relationship with GLS, in asymptomatic patients with degenera-
tive MR.
Method and results: Comprehensive transthoracic echocardiography
including 2DSt quantification was performed in 135 consecutive asymptom-
atic patients with moderate to severe degenerative MR and preserved LV
function. BNP was correlated with age (r=0.28, p=0.009), indexed LV end-
systolic diameter (r=0.30, p=0.0006), indexed LA volume (r=0.51, p<0.0001),
E/Ea ratio (r=0.33, p<0.0001), systolic pulmonary pressure (r=0.24, p=0.006)
and GLS (r=–0.54, p<0.0001). On multiple regression analysis, only indexed
LA volume and GLS were independently associated with BNP (=1.1±0.4,
p=0.002 and =–6.6±1.4, p<0.001, respectively). According to the median of
BNP, patients with high BNP level had significant reduced event-free survival
(21±8% vs. 75±6%, p<0.0001). A GLS<23% was also associated with lower
event-free survival (85±6% vs. 33±7%, p<0.0001). In Cox multivariate anal-
ysis, after adjustment for age, sex, E/Ea ratio and indexed end-systolic diam-
eter, only indexed LA volume (hazard ratio [HR]=1.01, 95% confidence
interval [CI]: 1.0-1.3, p=0.036), GLS<23% (HR=3.3, 95% CI: 1.1-9.9,
p=0.03) and BNP<41 pg/ml (HR=3.5, 95%CI: 1.7-7.2, p=0.001) were inde-
pendent determinants of cardiac event-free survival.
Conclusion: In asymptomatic degenerative MR, LV longitudinal function
and LA volume are the main determinants of BNP release. BNP is a powerful
independent predictor of cardiac events. Assessment of plasma BNP level, LA
volume, and LV longitudinal function may help to improve risk stratification
and the management of these patients.
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Background: Detection of high-risk patients is an important issue for the
management of aortic valve stenosis (AS). Previous studies have shown that
plasma levels of BNP increases with AS severity and may provide prognostic
information. However, these studies were impeded by selection bias and inclu-
sion of relatively young patients, or their small sample sizes. In addition, a
wide overlap of BNP values between symptomatic and asymptomatic patients
was observed. Thus, the aim of the present study was to evaluate the prognosis
value of BNP in a cohort of elderly patients with AS.
Method: Nt-proBNP was measured at entry in the study and patients were
prospectively followed on a yearly basis. Inclusion criteria were age 70
years, at least mild AS, absence of symptoms, and absence of significant renal
insufficiency.
Results: 346 patients were included. Mean age was 79±6 years. 225 had
severe AS and 196 were symptomatic. Nt-proBNP increases with NYHA class
and hemodynamic parameters (p<0.0001). However, Nt-proBNP values were
widely scattered with a large overlap between symptomatic and asymptomatic
patients. Consequently, Nt-proBNP had poor sensibility and specificity for the
detection of patients with severe symptomatic AS (ROC curve =0.73, sensi-
tivity=47%, specificity=85%). Among the 150 asymptomatic patients, 12
underwent a prophylactic surgery and follow-up was in 126 (91%). Patients
with NT-proBNP<300 pg/ml had a better outcome than patients with Nt-
proBNP between 300 and 700 pg/ml, or >700 pg/ml (99% vs. 90% and 86%
event free survival at one year, p=0.004). However, Nt-proBNP was not an
independent predictor of outcome after adjustment for valve area, age and
gender (p=0.30).
Conclusion: Our study is the first to enhance the limits of Nt-proBNP for
the evaluation of AS patients. Our data show that Nt-proBNP is not an inde-
pendent prognostic factor of outcome and raises caution regarding a patients’
management based on BNP value especially in the elderly population.
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Objectives: The human matrix associated serine protease inhibitor “tissue
factor pathway inhibitor-2” (TFPI-2) is known to have inhibitory activity
towards matrix metalloproteases (MMPs), which play an important role in the
process of aortic valve stenosis (AS). Reduced synthesis of TFPI-2 has been
related to numerous pathophysiological processes such as atherosclerosis.
Since AS is an atherosclerosis-like process, we hypothesized that TFPI-2
might play a protective role in the progression of AS.
Methods: Calcified aortic valves (n=28) were obtained from patients
undergoing aortic valve replacement (16 men; 68.7±2.2 years;indexed aortic
valve area 0,42±0,03 cm²/m²). Valvular expression and localization of TFPI-2
and other components of atherosclerosis were evaluated by immunohis-
tochemistry. TFPI-2 expression was further analyzed using a home-made
ELISA and by Western blot. Finally, we evaluated TFPI-2 expression in pri-
mary valve myofibroblast cultures obtained from explanted valves after colla-
genase digestion (n=12).
Results: We demonstrated TFPI-2 expression in aortic valves, which was
found to be significantly lower in the calcified regions as compared to non cal-
cified zones (1705±266 vs 2997±433 pg/mg; p=0.001). In contrast, there was
an overexpression in calcified regions as compared to non calcified zones of
pro-atherosclerotic factors (tissue factor (837±131 vs 476±95 pg/mg; p=0.01)
and MMP9 (97±46 vs 38±7 pg/mg; p=0.04)) and pro-calcifying proteins
(osteopontin (46±11 vs 4.6±1.3 ng/mg; p<0.0005)). Finally we showed that
cultured valve myofibroblasts express variable amounts of TFPI-2, inducible
by IL-1 or TNF- stimulation. Baseline TFPI-2 expression seemed to be
inversely correlated to the degree of calcification of the valves.
Conclusion: We showed here for the first time, the presence of TFPI-2 in
calcified human aortic valves. The inverse correlation between TFPI-2 expres-
sion and valve calcification might suppose a protective role for TFPI-2 in
aortic valve disease.
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Purpose: Whether surgical or percutaneous, mitral commissurotomy is
hampered by late mitral restenosis. Percutaneous mitral commissurotomy
(PMC) can be used to treat restenosis. Series with long-term follow-up are
necessary to evaluate the usefulness of PMC in deferring surgery.
Methods: We studied 163 patients (pts) who underwent PMC because of
restenosis a mean period of 16±8 years after previous commissurotomy
